BioPharma Pharma QC

C2 Pharma Announces Launch of New API, Oxybuprocaine Hydrochloride, Enhancing Pain Management Solutions

Oxybuprocaine (also known as Benoxinate), is a local topical anesthetic used especially in ophthalmology and otolaryngology for short term medical procedur...

 March 11, 2024 | News

Chime Biologics Secures ISO/IEC 27001:2022 Certification, Bolstering Information Security

Chime Biologics, a leading global CDMO that enables its partners' success in biologics,announced that it has obtained ISO/IEC 27001:2022 certification on i...

 March 08, 2024 | News

Australian Telix Boosts US Presence with IsoTherapeutics Acquisition

Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract m...

 February 27, 2024 | News

Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process

  This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...

 February 23, 2024 | News

Mastering the Regulatory Puzzle: Strategies for Biopharmaceutical Success in APAC's Diverse Landscape

The Asia-Pacific (APAC) region, with its burgeoning economies and rapidly expanding healthcare infrastructure, is a fertile ground for biopharmaceutical in...

 February 20, 2024 | Regulatory

FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...

 February 15, 2024 | News

Luye Pharma Licenses Rivastigmine Patch to Myung In Pharm for South Korea Commercialization

The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...

 February 06, 2024 | News

Glenmark, Jiangsu Alphamab, and 3D Medicines Ink Global License Deal for Envafolimab (KN035)

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...

 January 26, 2024 | News

Molecule AI Spearheads Pharmaceutical Transformation with AI-Driven Drug Discovery Innovations

Molecule AI, on a mission to accelerate drug discovery through the innovative use of artificial intelligence, is making significant...

 January 20, 2024 | News

Mundipharma Greenlights European Approval for REZZAYO® in Treating Adult Invasive Candidiasis

The approval is based on the positive results of the pivotal Phase III ReSTORE clinical trial and is supported by STRIVE's Phase II clinical trials and a...

 January 01, 2024 | News

Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager

 The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...

 January 01, 2024 | News

NOW tested over thirty Berberine supplements after surveying the online marketplace for questionable products.

Goldenseal is one well-known example of a berberine-rich plant and enjoys a long history of medicinal use by Native American tribes. Berberine has rece...

 December 27, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

 December 22, 2023 | News

Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index

In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...

 December 15, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close